|
Match
|
Document |
Document Title |
|
|
6503915 |
Composition and method for treatment of cerebral ischemia
A composition and method for the treatment of cerebral ischemia is disclosed, the composition is a mixture of caffeine and alcohol and is used to treat cerebral ischemia by administering to a...
|
|
|
6503488 |
Topical compositions including deodorant compositions
A topical composition for use in a variety of environments includes an active component, e.g., acetylsalicylic acid, a solvent mixture for the active components and, optionally, a silicone...
|
|
|
6503916 |
Treatment of ischemic brain injury
A composition and method adapted for the treatment of ischemic brain injury is disclosed, which includes applying hypothermic conditions to a subject within 5 hours after onset of brain injury and...
|
|
|
6451773 |
Chitosan formulation with azelaic acid and other actives for the treatment of acne
A composition for treating acneiform eruption containing: (a) a chitosan having a molecular weight ranging from about 500,000 to about 5,000,000 g/mole and a degree of deacylation greater than 80%;...
|
|
|
6444665 |
Method for treating pain
The present invention provides a method for treating pain using an atypical antipsychotic compound.
|
|
|
6436916 |
Ibuprofen-aspirin and hydroxymethylacylfulvene analogs
Ibuprofen-aspirin compounds useful in treating aspirin or ibuprofen-treatable conditions and hydroxymethylacylfulvene analogs useful as antitumor drugs.
|
|
|
6395720 |
Synergistically acting compositions for selectively combating tumor tissue
According to the invention, compositions are made available which have a strong cytotoxic effect which is largely selective on tumor tissue. The invention is based on the fact that certain benzoic...
|
|
|
6368615 |
Contact lens having a pharmaceutical agent releasably disposed therein
A contact lens having a pharmaceutical agent releasably disposed therein. The lens itself comprises a polymer of an unsaturated carboxylic acid ester of salicylic acid, the unsaturated carboxylic...
|
|
|
6361792 |
Lipid dispersions and methods of use
Methods for preventing or ameliorating the transient adverse physiological response to particulate dispersions (TAPR response) when these dispersions are administered parenterally to a patient. The...
|
|
|
6323188 |
Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins
Disclosed is the method of reducing the incidence and severity of stroke, primary heart attack, and any subsequent heart attack or stroke in humans by daily administration of an effective amount of...
|
|
|
6306843 |
Method for producing stable acetylsalicylic acid solutions
In a method for producing stable acetylsalicylic acid solutions with pharmaceutically acceptable non-aqueous organic solvents such as, e.g., dimethylisosorbide, propylene glycol or diethylene...
|
|
|
6287601 |
Topical nitric oxide donor compositions
Compositions and methods of the topical treatment of equine laminitis are disclosed. In particular, combinations of a fast acting nitric oxide (NO) donor, a sustained acting NO donor and an NSAID...
|
|
|
6268355 |
Stable aspirin-containing preparations for external use
External preparations containing Aspirin which are stored for a long term and superior in dermal absorbability. The preparations are prepared by mixing Aspirin together with at least one substance...
|
|
|
6218373 |
Formulations containing hyaluronic acid
A method of treating a disease of condition administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a...
|
|
|
6203819 |
Dietary supplement and method of treatment for diabetic control
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes...
|
|
|
6204245 |
Treatment of narcolepsy with immunosuppressants
The invention provides compositions and methods for treatment of narcolepsy or isolated cataplexy. Such methods entail administering a therapeutically effective regime of at least one...
|
|
|
6201022 |
Methods for treating neurotransmitter-mediated pain syndromes by topically administering an omega fatty acid
Methods are disclosed for treating neurotransmitter-mediated pain syndromes such as fibromyalgia. Such methods include topically administering an effective amount of a composition containing an...
|
|
|
6193986 |
Oily composition with increased stability and process for producing the same
An oily composition having excellent storability and forming no precipitate of an ingredient selected from the group of gelatin and gum arabic during the storage for a long period of time is...
|
|
|
6177414 |
Starburst conjugates
Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These...
|
|
|
6159505 |
Compositions for the treatment of migraine, containing potassium, magnesium and pyridoxine
Compositions for the treatment and prevention of migraine or stress headaches wherein there is supplied a combination of potassium, magnesium and pyridoxine optionally in association with other...
|
|
|
6160018 |
Prophylactic composition and method for alzheimer's Disease
A method of preventing or delaying the onset of symptoms of Alzheimer's Disease includes the step of administering to a patient in need of such treatment a composition having an effective...
|
|
|
6156299 |
Topical compositions and methods for treating pseudofolliculitis barbae and ingrown hair
Topical compositions and methods are disclosed for the treatment of pseudofolliculitis barbae and ingrown hair. The compositions comprise acetylsalicylic acid, propylene glycol, glycerine, and...
|
|
|
6127352 |
Pharmaceutical compositions with analgesics containing codeine
Compositions for the relief of pain containing acetyl salicylic acid or acetaminophen as a peripherally acting analgesic and codeine as a centrally acting agent.
|
|
|
6121249 |
Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
Disclosed is the method of reducing the incidence and severity of atherosclerosis, atherosclerotic central nervous system disease, claudication, coronary artery disease, homocystine related...
|
|
|
6100249 |
Use of aspirin for the manufacture of a medicament for implanting an embryo into the uterine endometrium
The invention provides the use of a cycloaygenase inhibitor such as the non-steroidal anti-inflammatory agent aspirin in the manufacture of a medicament to enhance perfusion of blood through the...
|
|
|
6071896 |
Suppression of thromboxane levels by percutaneous administration of aspirin
A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing the...
|
|
|
6071514 |
Methods for treating thrombotic disorders
The present invention provides a method of treatment for patients with a variety of thrombotic disorders including, but not limited to, stroke, venous thrombosis, myocardial infarction, unstable...
|
|
|
6051566 |
Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
Non-steroidal anti-inflammatory drugs proved to be effective drugs for combating and preventing asthma if administered by inhalation. Useful are for instance acetylsalicylic acid, and indomethacin,...
|
|
|
6045827 |
Treatment of equine laminitis
Compositions and methods of the topical treatment of equine laminitis are disclosed. In particular, combinations of a fast acting nitric oxide (NO) donor, a sustained acting NO donor and an NSAID...
|
|
|
6037338 |
Method for treating aspirin-treatable cancers
The present invention relates to a biodegradable plastic made from a combination of at least one synthetic plastic polymer, at least one natural polymer and a natural polymer attacking agent and...
|
|
|
6017900 |
Topical composition containing hyaluronic acid and nsaids
A pharmaceutical composition comprising a plurality of effective non-toxic dosage amounts of a composition for topical administration to the site of pathology or trauma of skin or exposed tissue of...
|
|
|
6011067 |
Antioxidant composition for the treatment of psoriasis and related diseases
The present invention deals with the combination of several synergistic antioxidants including enzymatic co-factors as adjuncts to therapy of desquamating inflammatory disorders, such as psoriasis....
|
|
|
5989578 |
Associations of active principles containing clopidogrel and an antithrombotic agent
The invention relates to a pharmaceutical composition containing an association of active principles, wherein the active principles are clopidogrel and aspirin, each constituent being present in a...
|
|
|
5985860 |
System for transdermal delivery of pain relieving substances
Compositions for pain relieving non-steroidal anti-inflammatory drugs and/or medicaments such as ibuprofen, methotrexate, capsaicin, diphenhydramine, aspirin, methyl-nicotinate and other...
|
|
|
5972916 |
Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
The invention provides a safe and economical nonprescription combination of acetaminophen, aspirin and caffeine (APAP/ASA/CAF) for use in treating migraine pain and the cluster of symptoms...
|
|
|
5955036 |
Process and apparatus for the agglomeration of hydrolytically sensitive substances by means of steam
In the process for the agglomeration of slightly soluble and hydrolytically sensitive substances, a powder of the slightly soluble substance is conducted, together with at least one water-soluble...
|
|
|
5948443 |
Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
The present invention pertains generally to the field of Public Health, including the prevention and treatment of coronary heart disease which is currently the first cause of death in the American...
|
|
|
5900412 |
Percutaneous/transdermal delivery of ASA and antithrombotic therapies based thereon
Topically applicable pharmaceutical/therapeutic alcoholic solution compositions, well suited for percutaneous/transdermal antithrombotic therapy, comprise an effective antithrombotic amount of...
|
|
|
5874422 |
Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particulate pharmaceutical preparations
The use of nonsteroidal anti-inflammatory agents as an addition to particulate pharmaceutical agent preparations can reduce side-effects on the cardiovascular system during administration.
|
|
|
5871766 |
Beta-carotene vitamin E therapy for inhibition of major vascular events
This invention is directed to a method for inhibiting the occurrence of a major vascular event in a subject whereby a subject is administered beta-carotene and/or vitamin E, either alone or in...
|
|
|
5827886 |
Composition for relief of arthritis-induced symptoms
A composition and method of using it for ameliorating inflammatory reactions and painful and other symptoms of the diseases of arthritis, lumbago, low back pain, myalgias and neuralgias. The...
|
|
|
5824666 |
Low PH, hydrolytically stable, cosmetic compositions containing acidic actives
The present invention relates to leave on, oil-in-water, skin care compositions, comprising: (A) from about 0.05% to about 20% of an acidic active ingredient, preferably having a solubility...
|
|
|
5762951 |
Effervescent composition and tablet made there from
The present invention relates to an acidic effervescent component for direct tableting of effervescent tablets and a process for its preparation.
|
|
|
5760024 |
Method of using aspirin to implant an embryo
The invention provides the use of a cyclooxygenase inhibitor such as the non-steroidal anti-inflammatory agent aspirin in the manufacture of a medicament to enhance perfusion of blood through the...
|
|
|
5756482 |
Method of attenuation of nervous system damage
A method is disclosed for attenuation of nervous system damage after injury which comprises administering therapeutic amounts of PREG, PREG-S, or esters of PREG or PREG-S together with an enhancer...
|
|
|
5736536 |
Method for treating vascular leak syndrome
A novel method for preventing, stabilizing or causing regression of vascular leak syndrome is disclosed. The method comprises administering to a patient in need thereof a compound selected from the...
|
|
|
5723453 |
Stabilized, water-soluble aspirin composition
A stabilized, essentially sodium free, alkaline and aspirin combination compound which is readily soluble in a preselected fluid, which when dissolved forms potassium acetylsalicylate. Such...
|
|
|
5709855 |
Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain
A composition for preventing or treating inflammation and/or pain by topical administration are disclosed. The composition contains an omega fatty acid in combination with spirulina. Preferably,...
|
|
|
5643960 |
Method of delaying onset of alzheimer's disease symptoms
The present invention relates, in general, to a method of preventing or delaying the onset of Alzheimer's disease and related neurodegenerative disorders. The method involves the administration to...
|
|
|
5574022 |
Method of attenuating physical damage to the spinal cord
A method is disclosed for attenuation of nervous system damage after injury which comprises administering therapeutic amounts of PREG, PREG-S, or esters of PREG or PREG-S together with an enhancer...
|